Research analysts at Wedbush issued their FY2029 EPS estimates for shares of Arcus Biosciences in a note issued to investors ...
The spring home-selling season is shaping up to be a challenging one for major homebuilders amid a trade war and rising ...
Equities researchers at Wedbush lifted their Q4 2025 earnings per share estimates for shares of CarMax in a research note ...
Tesla is now the world’s most valuable car company, with a market capitalization of nearly £1 trillion as of 2025. That’s ...
Analyst Dan Ives thinks Tesla stock could soar from current levels thanks to a potential $1 trillion catalyst.
Nvidia (NASDAQ: NVDA) has been one of the best-performing stocks on the planet in recent years. In fact, over the past two ...
Nvidia is set to report fourth-quarter results after the market closes Wednesday, with analysts widely bullish on the AI ...
The EV manufacturer earned a $110 million gross profit at its core automotive business in the fourth quarter, a milestone ...
Shares of Avalo Therapeutics (NASDAQ:AVTX) climbed on Friday as Wedbush launched its coverage with an Outperform recommendation and an $18 per share target, citing the potential of the biotech’s lead ...